Brief: Sensus Healthcare's Srt Treatment Shows Promise In Treating Cutaneous Mast Cell Tumors Among Pet Patients
17/05/2023 13:07
Sensus Healthcare Inc SRTS.O :
* SENSUS HEALTHCARE'S SRT TREATMENT SHOWS PROMISE IN
TREATING
CUTANEOUS MAST CELL TUMORS AMONG PET PATIENTS
Source text for Eikon: ID:nGNX2fF6wV
Further company coverage: SRTS.O
Recent news on Sensus Healthcare
See all newsBrief: Sensus Healthcare - Enters $15 Million Revolving Credit Facility With City National Bank Of Florida - SEC Filing
Brief: Sensus Healthcare Announces Amicable Resolution Of Commercial Dispute With SkinCure Oncology
Sensus Healthcare Q1 revenue falls 59% on absence of largest customer
Brief: Sensus Healthcare Q1 Net Income USD -2.626 Million
Brief: Sensus Healthcare Files Lawsuit Against Skincure Oncology For Breach Of Contract